|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income: | |
| Interest income | |
| Other income | |
| Total other income | |
| Net loss | |
| Unrealized gain on marketable securities | |
| Total other comprehensive gain | |
| Comprehensive loss | |
| Net loss per share, basic (in dollars per share) | |
| Net loss per share, diluted (in dollars per share) | |
| Weighted-average common shares outstanding, basic (in shares) | |
| Weighted-average common shares outstanding, diluted (in shares) |
Loading...
